Scientists hunt for genetic clues to cancer treatment success
NCT ID NCT00628368
First seen Feb 12, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study analyzed tumor and blood samples from 160 people with esophageal or rectal cancer to find genetic markers that predict how well they respond to chemoradiotherapy given before surgery. The goal was to identify which patients are most likely to benefit from this treatment approach. No new treatment was tested; instead, researchers looked for biological clues in existing samples.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.